• CME

  • Diabetic Macular Edema: Pathophysiology and Evolving Treatment Strategies

    Earn CME Credit »
  • Author(s)/Faculty: James M. Klancnik, MD; Keith A. Warren, MD; Szilárd Kiss, MD
    Source: Ocular Surgery News
    Type: Monograph Articles/Items: 5
    Release Date: 4/10/2012 Expiration Date: 4/10/2013
    Credit Type: CME Number of Credit(s): 1.25
    Cost: Free Provider: Vindico Medical Education

  • Diabetic retinopathy and diabetic macular edema are two of the earliest and most common manifestations of type 2 diabetes mellitus, the incidence of which is increasing exponentially, putting hundreds of thousands of patients at risk for visual loss and blindness each year. Understanding how the progression of the disease will affect vision should encourage clinicians to be more vigilant about monitoring the patient’s overall health and early symptoms of diabetes-related issues. Once the disease is detected, careful management is critical to maintain vision. Increasing evidence suggests that anti-VEGF agents may be effective in the treatment and prevention of diabetic macular edema.

Sponsorship Statement: This continuing medical education activity is jointly sponsored by Vindico Medical Education and

Support Statement: This activity is supported by an educational grant from genentech_sm.gif

Target Audience: The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the treatment of patients with retinal diseases.

Learning Objectives: At the conclusion of this activity participants should be able to:

  • Analyze the science related to the pathogenesis of diabetic macular edema to be better able to comprehend evolving treatment regimens.
  • Evaluate Diabetic Retinopathy Clinical Research Network (DRCR.net) study data that aims to improve the current standard of care for DME.
  • Employ best practices for the overall management of diabetic macular edema based upon a thorough evaluation of ongoing clinical studies.

Course Chair:
Szilárd Kiss, MD
Director of Clinical Research
Assistant Professor of Ophthalmology
Weill Cornell Medical College
New York, NY

Faculty:
Keith A. Warren, MD
President & CEO
Warren Retinal Associates
Clinical Professor of Ophthalmology
University of Kansas
Overland Park, KS

James M. Klancnik Jr., MD
Vitreous Retina Macula Consultants of New York
New York, NY

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Ocular Surgery News® . Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 10, 2012 to April 10, 2013.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Planning Committee and Faculty:
Szilárd Kiss, MD
Keith A. Warren, MD
James M. Klancnik Jr., MD

External Reviewer:
Mitchell Goff, MD

Medical Writer:
Valerie Zimmerman, PhD

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Szilárd Kiss, MD
Consulting Fees: Alimera, Allergan, OIS, Optos
Fees for Non-CME Services: Alimera, Allergan, Optos
Contracted Research: Allergan, Genentech, Optos, Regeneron

Keith A. Warren, MD
 Consulting Fees: Alcon Laboratories, Inc., DORC, Genentech
Fees for Non-CME Services: Alcon Laboratories, Inc., DORC, Genentech

James M. Klancnik
 Contracted Research: Genentech, Regeneron

External Reviewr reports the following relationship(s):
Mitchell Goff, MD
No relevant financial relationships to disclose

Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose

Vindico Medical Education and Ocular Surgery News® staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2012 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Ocular Surgery News® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Ocular Surgery News®. Neither Vindico Medical Education, Ocular Surgery News®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.